Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Complete Genomics Inc (GNOM) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Complete Genomics Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1361103.
Total stock buying since 2010: $19,672,143.
Total stock sales since 2010: $11,889,303.
Total stock option exercises since 2010: $176,602.
▪ Statistics of price movements of GNOM
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2012 | 0 | $0 | 3,273,936 | $9,534,145 | 4,166 | $0 |
| 2011 | 220,623 | $822,147 | 747,760 | $2,355,158 | 121,067 | $176,602 |
| 2010 | 2,094,444 | $18,849,996 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2012-11 | 0 | $0 | 0 | $0 | 4,166 | $0 |
| 2012-07 | 0 | $0 | 1,207,936 | $3,305,023 | 0 | $0 |
| 2012-03 | 0 | $0 | 2,066,000 | $6,229,122 | 0 | $0 |
| 2011-12 | 200,000 | $610,000 | 731,760 | $2,242,350 | 0 | $0 |
| 2011-11 | 0 | $0 | 0 | $0 | 3,332 | $0 |
| 2011-10 | 0 | $0 | 0 | $0 | 80,000 | $120,000 |
| 2011-09 | 0 | $0 | 16,000 | $112,808 | 16,000 | $24,000 |
| 2011-08 | 10,000 | $79,360 | 0 | $0 | 0 | $0 |
| 2011-05 | 10,623 | $132,787 | 0 | $0 | 0 | $0 |
| 2011-02 | 0 | $0 | 0 | $0 | 21,735 | $32,602 |
| 2010-11 | 2,094,444 | $18,849,996 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-11-30 | Shuster Lewis (Director) | Option Ex | 833 | .00 | 0 |
| 2012-11-30 | Caskey C Thomas (Director) | Option Ex | 833 | .00 | 0 |
| 2012-11-30 | Wall Robert T (Director) | Option Ex | 833 | .00 | 0 |
| 2012-11-30 | Waite Charles P Jr (Director) | Option Ex | 1,667 | .00 | 0 |
| 2012-07-13 | Isaly Samuel D | Sale | 479,300 | 2.51 | 1,203,522 |
| 2012-07-12 | Isaly Samuel D | Sale | 220,700 | 2.85 | 628,995 |
| 2012-07-11 | Isaly Samuel D | Sale | 507,936 | 2.90 | 1,472,506 |
| 2012-03-16 | Ovp Venture Partners Vi Lp (10% Owner) | Sale | 450,000 | 2.92 | 1,316,250 |
| 2012-03-16 | Waite Charles P Jr (Director) | Sale | 450,000 | 2.92 | 1,316,250 |
| 2012-03-15 | Ovp Venture Partners Vi Lp (10% Owner) | Sale | 165,059 | 2.89 | 477,185 |
| 2012-03-15 | Waite Charles P Jr (Director) | Sale | 165,059 | 2.89 | 477,185 |
| 2012-03-14 | Ovp Venture Partners Vi Lp (10% Owner) | Sale | 142,941 | 3.09 | 441,401 |
| 2012-03-14 | Waite Charles P Jr (Director) | Sale | 142,941 | 3.09 | 441,401 |
| 2012-03-13 | Ovp Venture Partners Vi Lp (10% Owner) | Sale | 275,000 | 3.20 | 879,725 |
| 2012-03-13 | Waite Charles P Jr (Director) | Sale | 275,000 | 3.20 | 879,725 |
| 2011-12-14 | Enterprise Partners Management Llc (10% Owner) | Buy | 100,000 | 3.05 | 305,000 |
| 2011-12-14 | Senyei Andrew E (Director) | Buy | 100,000 | 3.05 | 305,000 |
| 2011-12-14 | Waite Charles P Jr (Director) | Sale | 200,000 | 3.05 | 610,000 |
| 2011-12-09 | Waite Charles P Jr (Director) | Sale | 42,800 | 3.00 | 128,442 |
| 2011-12-08 | Waite Charles P Jr (Director) | Sale | 49,050 | 3.00 | 147,394 |
| 2011-12-07 | Waite Charles P Jr (Director) | Sale | 110,840 | 3.09 | 342,716 |
| 2011-12-06 | Waite Charles P Jr (Director) | Sale | 85,150 | 3.13 | 266,348 |
| 2011-11-30 | Senyei Andrew E (Director) | Option Ex | 1,666 | .00 | 0 |
| 2011-11-30 | Waite Charles P Jr (Director) | Option Ex | 1,666 | .00 | 0 |
| 2011-10-27 | Drmanac Radoje T (Chief Scientific Officer) | Option Ex | 80,000 | 1.50 | 120,000 |
| 2011-09-21 | Reid Clifford A (Chief Executive Officer) | Sale | 8,000 | 6.80 | 54,440 |
| 2011-09-21 | Reid Clifford A (Chief Executive Officer) | Option Ex | 8,000 | 1.50 | 12,000 |
| 2011-09-20 | Reid Clifford A (Chief Executive Officer) | Sale | 8,000 | 7.30 | 58,368 |
| 2011-09-20 | Reid Clifford A (Chief Executive Officer) | Option Ex | 8,000 | 1.50 | 12,000 |
| 2011-08-08 | Raffel Keith (SVP & Chief Commercial Officer) | Buy | 10,000 | 7.94 | 79,360 |
| 2011-05-26 | Strand Advisors, Inc. (10% Owner) | Buy | 10,623 | 12.50 | 132,787 |
| 2011-02-09 | Martin Bruce K (SVP of Product Development) | Option Ex | 21,735 | 1.50 | 32,602 |
| 2010-11-16 | Essex Woodlands Health Ventures Fund Viii-b Lp (10% Owner) | Buy | 602,778 | 9.00 | 5,425,002 |
| 2010-11-16 | Prospect Management Co. Iii, L.l.c. (10% Owner) | Buy | 333,333 | 9.00 | 2,999,997 |
| 2010-11-16 | Senyei Andrew E (Director) | Buy | 111,111 | 9.00 | 999,999 |
| 2010-11-16 | Barkas Alexander E (Director) | Buy | 333,333 | 9.00 | 2,999,997 |
| 2010-11-16 | Enterprise Partners V L P (10% Owner) | Buy | 111,111 | 9.00 | 999,999 |
| 2010-11-16 | Orbimed Advisors Llc (10% Owner) | Buy | 602,778 | 9.00 | 5,425,002 |
Insider trading activities including stock purchases, stock sales, and option exercises of GNOM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Complete Genomics Inc (symbol GNOM, CIK number 1361103) see the Securities and Exchange Commission (SEC) website.